ABSTRACT Background: Severe bronchopulmonary dysplasia (BPD) might be associated with an accelerated age-related decline of lung function. Methods: 14 individuals were studied longitudinally at 1564, 1863 and 3863.2 years. Information on personal history was completed, and lung function testing and skin prick testing were performed. Longitudinal data were compared intra-individually and with matched controls from the NHANES III dataset. Results: The ratio of residual volume/total lung capacity (RV/TLC) increased markedly from 25.967.0% to 39.366.8%. A significant time-effect was found compared to controls for the forced vital capacity (FVC) which decreased more rapidly than expected. Flow values were at the lower limit of normal range but remained relatively stable over time. Some individuals had completely normal lung function results. Conclusion: Increasing static pulmonary hyperinflation with age is indicative of bronchiolar dysfunction or early emphysematous changes in survivors of severe BPD. Susceptibility for long-term sequelae shows significant variability.
In 1967, Northway et al 1 reported on harmful effects of barotrauma and oxygen toxicity in prematurely born children, causing an acquired lung disease called bronchopulmonary dysplasia (BPD) that was characterised by patchy bronchoalveolar scarring, atelectases and overexpansion. With the introduction of lung protective ventilation and the advent of surfactant, the features of BPD have changed. 2 Residual lung function abnormalities, mainly airflow obstruction and hyperinflation, 3 were found in young adults, and emphysematous changes found by CT raised the question whether BPD might ultimately affect pulmonary ageing, for example, by leading to the development of chronic obstructive pulmonary disease. 4 5 A unique cohort of 20 survivors of severe BPD born before the advent of lung protective ventilation and surfactant has been observed longitudinally into adulthood. Neonatal pulmonary management had included pressure-controlled mechanical ventilation with peak inspiratory pressures up to 40 cm H 2 O adjusted to repeated blood gas analyses; The perinatal characteristics were birthweight 17956456 g (mean6SD), gestational age 31.862.9 weeks, highest documented peak inspiratory pressures 2664.5 cmH 2 O, endotracheal intubation for 38 (range 4e103) days and FiO 2 $0.4 for 36 (range 4e96) days. Five individuals had been tracheotomised for an extended period. The first sequential lung function study in 1983 and 1987 had revealed mean flow parameters around the lower limit of normal, but no significant changes over time.
Six individuals reported a variety of persisting respiratory symptoms, mainly asthma, cough or shortness of breath during exercise. Four individuals with hay fever were sensitised to pollens; an additional person was sensitised to cat allergens without symptoms. Two individuals were on occasional inhaled corticosteroids. There were four current smokers (8e16 pack-years) and one former smoker. Six individuals had shown bronchial hyperreactivity to methacholine in 1987, two of whom still reacted 
